Sign in

CIK 0001736243

  • Emerging growth company

Acurx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ACXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 917-533-1469
Business address
259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
Former names
Acurx Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-20 Sailer Carl Director Grant or award · Stock Option +2,150 2,150
2025-01-06 Sailer Carl Director Purchase +24,631 $1.02 $25K 137,183
2025-01-06 Sailer Carl Director Purchase · Warrants for Common Stock +24,631 24,631
2024-06-17 Sailer Carl Director Grant or award · Stock Option +12,000 12,000
2024-01-19 Sailer Carl Director Option exercise +19,737 $3.55 $70K 112,552
2024-01-19 Sailer Carl Director Option exercise · Warrants for Common Stock −19,737 0
2023-06-15 Sailer Carl Director Grant or award · Stock Option +10,000 10,000
2022-07-27 Sailer Carl Director Purchase +19,737 $3.80 $75K 92,815
2022-07-27 Sailer Carl Director Purchase · Warrants for Common Stock +19,737 19,737
2022-07-27 Sailer Carl Director Purchase · Warrants for Common Stock +19,737 19,737
2021-11-23 Sailer Carl Director Purchase +5,161 $4.84 $25K 73,078
2021-07-01 Sailer Carl Director Grant or award · Stock Option +50,000 50,000
2021-06-29 Sailer Carl Director Purchase +12,500 $6.00 $75K 67,917

Page 1 of 1 · 13 trades